[5-FU concentration in portal blood after oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU)].
D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004067:Digestive System Neoplasms / Q000097:blood* / Q000188:drug therapy; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood* / Q000493:pharmacokinetics; D006801:Humans; D000922:Immunotoxins; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use*; D011168:Portal System; D005719:gamma-Globulins / Q000008:administration & dosage / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D004338:Drug Combinations; D000922:Immunotoxins; C045927:K-18 conjugate; D005719:gamma-Globulins; C017367:carmofur; D008558:Melphalan; D005472:Fluorouracil